Back to journals
Academic Journal

Neuroscience and Biobehavioral Reviews

22 Papers Indexed in Blossom

Data updated

Publication Landscape

How the 22 psychedelic papers Blossom tracks from Neuroscience and Biobehavioral Reviews line up by year, topic and compound. This is the journal's psychedelic-research output in Blossom's records as of July 2026; its full catalogue is much larger.

How much psychedelic research does Neuroscience and Biobehavioral Reviews carry?

Sourced

Tracked papers by publication year. Click a year for the running total.

4papers published in 2020

+300% vs 2019

10 published by 2020

Browse papers→

Don't read as the journal's total output: only the 22 of 22 tracked psychedelic papers from Neuroscience and Biobehavioral Reviews with a recorded publication date are counted, and Blossom tracks only psychedelic-relevant papers, so the full catalogue is much larger. The current year is still filling in.

What does Neuroscience and Biobehavioral Reviews publish on?

Sourced

Tracked papers per topic. Orange marks the largest research focus.

Anxiety Disorders
9
Neuroimaging & Brain Measures
9
Depressive Disorders
8
Addiction & Substance Use
4
Neurocognitive Disorders
3
PTSD
3
Personality & Trait Factors
3
Interpersonal Functioning & Social Connectedness
3
Other
15

Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not the journal's full catalogue.

Which compounds does Neuroscience and Biobehavioral Reviews cover?

Sourced

Tracked papers per compound. Orange marks the most-covered compound.

Psilocybin
7
Ketamine
5
MDMA
5
LSD
3
Ayahuasca
2
Mescaline
2
DMT
1
5-MeO-DMT
1

Don't read shares as adding to 100%: a paper studying several compounds counts once per compound, and placebo comparator arms are not shown. These are the psychedelic-relevant papers Blossom tracks.

Research Footprint

Neuroscience and Biobehavioral Reviews has 22 tracked papers indexed in Blossom (2015–2025) from 98 authors, most often covering Psilocybin, Ketamine and MDMA, across Anxiety Disorders, Neuroimaging & Brain Measures and Depressive Disorders.

Published Papers

Open Accessmeta

Insights on Psychedelics: A Systematic Review of Therapeutic Effects

This systematic review (s=98) examining psychedelic-catalysed insight found that 86% of studies showed insight was linked to therapeutic improvement, with insight being dose-dependent and significantly higher than placebo in 93% of comparative studies, suggesting insight may be a key mechanism in psychedelic therapy.

Published
Journal
Neuroscience and Biobehavioral Reviews
Authors
Kugel, J., Laukkonen, R., Yaden, D. B., Yücel, M., Liknaitzky, P.
Paywallmeta

Who Are You After Psychedelics? A Systematic Review and a Meta-Analysis of the Magnitude of Long-Term Effects of Serotonergic Psychedelics on Cognition/Creativity, Emotional Processing and Personality

This systematic review & meta-analysis (2024; s=10; n=304) synthesized data from contemporary studies, including both randomised and non-randomised controlled trials, to evaluate lasting effects of serotonergic psychedelics on cognition, creativity, emotional processing, and personality. Overall, no statistically significant effects were observed for most outcome measures; however, a meta-analysis of emotional recognition outcomes revealed faster reaction times in the active treatment groups for disgust and sadness.

Published
Journal
Neuroscience and Biobehavioral Reviews
Authors
Solaja, I., Haldane, K., Mason, N., Weiss, B., Xu, X., Xu, M., Nikolin, S., Jayasena, T., Millard, M., Brett, J., Bayes, A., Loo, C. K., Martin, D. M.
Open Accessmeta

Synthetic surprise as the foundation of the psychedelic experience

This hypothesis paper proposes that psychedelic agents like LSD and psilocybin induce altered states of consciousness by activating the 5-HT2A receptor system, leading to a state of synthetic surprise. This concept is based on recent understandings of serotonin's role in signaling surprise and is framed within the predictive coding framework, where surprise is seen as a mismatch between expectations and sensory input. The paper suggests that psychedelics disrupt maladaptive patterns by dynamically interacting with top-down expectations and sensory data, with implications for their clinical use, particularly emphasizing their ability to induce surprise to promote therapeutic effects.

Published
Journal
Neuroscience and Biobehavioral Reviews
Authors
De Filippo, R., Schmitz, D.
Paywallmeta

Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results

This systematic review (s=51) examines fMRI studies on the acute effects of psychedelics like psilocybin, LSD, and ketamine on the human brain. The review highlights significant methodological inconsistencies across studies, including 54% not meeting contemporary Type I error correction or motion artefact control standards. Despite these limitations, convergent findings indicate that psilocybin and LSD affect the connectivity architecture of the sensorimotor-association cortical axis, while ketamine increases activation in the dorsomedial prefrontal cortex.

Published
Journal
Neuroscience and Biobehavioral Reviews
Authors
Linguiti, S., Vogel, J. W., Sydnor, V. J., Pines, A., Wellman, N., Basbaum, A., Eickhoff, C. R., Eickhoff, S. B., Edwards, R. R., Larsen, B., McKinstry-Wu, A., Scott, J. C., Roalf, D. R., Sharma, V., Strain, E. C., Corder, G., Dworkin, R. H., Satterthwaite, T. D.
Open Accessmeta

The Relationship Between the Default Mode Network and the Theory of Mind Network as Revealed by Psychedelics- A Meta-Analysis

This meta-analysis (s=88, n=2122) investigates the overlap between the Default Mode Network (DMN) and the Theory of Mind (ToM) networks, and their modulation by psychedelics. It reveals that the cingulate cortex plays a crucial role in the overlap between these networks, and psychedelics affect their neural relationship, potentially explaining their impact on self-perception and social cognition.

Published
Journal
Neuroscience and Biobehavioral Reviews
Authors
Soares, C., Gonzalo, G., Castelhano, J. M., Castelo-Branco, M.
Paywallmeta

Don’t Be Afraid, Try to Meditate- Potential Effects on Neural Activity and Connectivity of Psilocybin-Assisted Mindfulness-Based Intervention for Social Anxiety Disorder: A systematic review

This systematic review (2022) explores the potential mechanisms by which combined psilocybin and mindfulness treatment could adjust anomalous neural activity underlying social anxiety disorder (SAD) and exert therapeutic effects. Proposed mechanisms include changes in cognitive processes like biased attention to threats linked to SAD by modulating connectivity of the salience network and more.

Published
Journal
Neuroscience and Biobehavioral Reviews
Authors
Kuypers, K. P. C.

Quick Facts

Papers Indexed
22
h-Index
305
Open Access
No
Publisher
Elsevier
Country
United Kingdom
Website
Visit